Studies transfusion practices in intensive care
Part of Blood & lymphatic clinical trials.
This trial looks at how blood transfusions were used in intensive care units and how that affected illness and survival. It may help improve transfusion decisions for future ICU patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were admitted to an intensive care unit at Besançon or Dijon university hospitals
- Your ICU admission was in the medical or surgical resuscitation unit
- Your ICU admission happened for any reason (the cause does not matter)
- Your ICU admission date was between January 1, 2012 and December 31, 2017
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether hands-on training for intensive care staff reduces infections in patients. If you are staying in the ICU for more than 48 hours, your data may be used to see if this training helps.
This study tests whether a new set of guidelines can help doctors and nurses give red blood cell transfusions more consistently in pediatric intensive care. It aims to make transfusion decisions safer and more uniform for children in the ICU.
This study uses artificial intelligence to better predict which ICU patients might need a blood transfusion. The goal is to make transfusion decisions more precise and personalized, potentially reducing unnecessary transfusions and improving care.
This trial tests whether extra support for ICU doctors and nurses helps them follow recommended guidelines for preventing and treating anemia (low red blood cells) in intensive care. It aims to improve patient outcomes by ensuring best practices are used.
This trial studies how to improve care for patients who come to the emergency room with a brain bleed not caused by injury. The goal is to find better ways to manage recovery and outcomes.
This trial tests a new treatment to protect and repair the layer of cells lining your blood vessels (glycocalyx) during sepsis. It aims to improve recovery from severe infections.
Hear when a new Transfusion Related Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.